Large-scale randomized controlled trials (RCTs) are lacking for most of these compounds
patients titrate up (0.25 0.51.01.72.4 mg weekly)
Compounded semaglutide affects digestion and blood sugar, so diabetes medications in particular need review
A 2025 study in JAMA Ophthalmology examined the association between semaglutide use and this condition
These combined effects are designed to support gradual, consistent weight loss when used as part of a structured health plan created at Genesis Lifestyle Medicine in Hendersonville
Reference: Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials by Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine R Tuttle, Richard E Pratley and Vlado Perkovic, 25 November 2024, The Lancet Diabetes & Endocrinology